Background: In Drosophila, the basic-helix-loop-helix protein DIMM coordinates the molecular and cellular properties of all major neuroendocrine cells, irrespective of the secretory peptides they produce. When expressed by nonneuroendocrine neurons, DIMM confers the major properties of the regulated secretory pathway and converts such cells away from fast neurotransmission and toward a neuroendocrine state. Results: We first identified 134 transcripts upregulated by DIMM in embryos and then evaluated them systematically using diverse assays (including embryo in situ hybridization, in vivo chromatin immunoprecipitation, and cell-based transactivation assays). We conclude that of eleven strong candidates, six are strongly and directly controlled by DIMM in vivo. The six targets include several large dense-core vesicle (LDCV) proteins, but also proteins in non-LDCV compartments such as the RNAassociated protein Maelstrom. In addition, a functional in vivo assay, combining transgenic RNA interference with MS-based peptidomics, revealed that three DIMM targets are especially critical for its action. These include two well-established LDCV proteins, the amidation enzyme PHM and the ascorbate-regenerating electron transporter cytochrome b 561-1 . The third key DIMM target, CAT-4 (CG13248), has not previously been associated with peptide neurosecretion-it encodes a putative cationic amino acid transporter, closely related to the Slimfast arginine transporter. Finally, we compared transcripts upregulated by DIMM with those normally enriched in DIMM neurons of the adult brain and found an intersection of 18 DIMM-regulated genes, which included all six direct DIMM targets.
Introduction
Neuroendocrine (NE) cells embody highly dedicated secretory cell states. Although different NE cells express unique arrays of neuropeptide-and/or neurohormone-encoding genes, all peptidergic NE cells nevertheless share many critical cellular functions. These functions reflect a common need for enzymes that conduct the posttranslational processing of numerous neuropeptide precursors and a need for the structural and regulatory components that execute large dense-core vesicle (LDCV) biogenesis, packaging, maturation, and trafficking [1, 2] . They also exhibit a choreographed capacity to modify their cell properties in response to changing physiological needs [3] . Many proteins are normally enriched in neuroendocrine tissues, and these may be coordinately regulated under different physiological states [4, 5] . Hence, NE programs of cell differentiation must reflect the operations of complex regulatory circuits, the details of which are only beginning to emerge. Examining the intracellular regulatory pathways that organize and modulate these specialized properties is an important question for cell biology and specifically is also critical to understanding NE cell physiology.
Important clues to understanding peptidergic cell biology may come from parallel studies of other neuronal secretory systems. Developmental programs of neurotransmitter expression are governed by dedicated transcriptional organizers. For example, serotonergic neuron differentiation (but not fate specification or survival) is substantially controlled by an ETS-domain transcription factor called PET-1 [6] . Likewise, dopaminergic (DA) neuron maturation is promoted by the ETS transcription factor AST-1, although it is not necessary for DA neuron generation or survival [7] . To what extent, therefore, do peptidergic secretory cells rely on similar transcriptional regulatory controls?
In the Drosophila model system, the transcription factor DIMM operates in peptidergic NE cells in many ways similar to PET-1 and AST-1 in aminergic cells. DIMM is specifically expressed in peptidergic NE cells [8] [9] [10] [11] [12] -termed LEAP cells (large, episodically releasing, amidating peptide producing) [13] . Notably, DIMM acts like a master cell regulator for professional secretory cell properties. It confers two cardinal features of the regulated secretory pathway (RSP) [14] onto neurons that otherwise do not display such properties [15] . The first property is generation and accumulation of LDCVs, which can house neuropeptides if these are available. The second property is activation of the complete posttranslational processing machinery, which is sufficient to produce biologically active peptides from neuropeptide precursors. These cell biological observations raise important questions as to how DIMM, a single transcription factor, can efficiently organize a complete and functional subcellular domain like the RSP. We reasoned that direct targets provide the most compelling basis to describe DIMM action mechanisms. Here we report a genome-wide screen to define candidate targets for DIMM regulation.
Results

Identification of Candidate Genes as Putative Direct DIMM Targets
To amass candidate DIMM targets in addition to peptidylglycine a-hydroxylating monooxygenase (Phm) [12] , we used genome-wide microarray profiling by overexpressing DIMM throughout the embryonic nervous system. To identify upregulated transcripts, we compared profiles from experimental (elav>dimm) and control (elav-GAL4) embryos at 22-26 hr and 28-32 hr after egg laying. We identified 134 candidate DIMM targets that were upregulated at least 1.5-fold following DIMM overexpression at both time points (see Table S3 available online). Many genes were also downregulated (Table S4) , but we did not study these further.
We used quantitative real-time PCR to confirm that 22 candidate targets were upregulated at least 1.5-fold by DIMM overexpression, and of these, 18 genes were upregulated at least 2-fold (Table S5 ). Many of the 134 candidates were not tested based on low expression levels, were tested but not detected by qPCR at this stage, or had primer sets that failed qualitycontrol tests. Finally, we focused on the 18 most highly elevated transcripts and reasoned that as DIMM targets, they would be expressed in the central nervous system (CNS), and their RNA levels would decline in a dimm loss-offunction mutant. Using conventional PCR, we found that transcripts of all 18 genes were in fact expressed in CNS (Table  S5 ). In addition, in first-instar larvae of severe dimm hypomorphs (Rev4/Rev8; [8] ), transcript levels for 11 of the 18 genes were significantly decreased. We therefore focused on these 11 genes; their identities and GO terms are listed in Table S6 .
Two of the eleven candidates, Phm and CG1275, were previously associated with peptidergic signaling. Consistent with previous findings, the inclusion of Phm provides internal validation to the profiling method. CG1275 encodes a cytochrome (Cyt) transmembrane electron transporter most related to the b 561-1 protein [16] . Cyt b 561-1 is specific to dense-core secretory vesicles that contain catecholamines or amidated peptides, as are found in chromaffin cells and elsewhere. Cyt b 561-1 regenerates ascorbate, which is an essential cofactor to support the biosynthetic functions of PHM [17, 18] from within the vesicles.
Evaluating the Eleven Candidate DIMM Targets
We performed three independent experiments to evaluate the degree to which the 11 candidate targets are strongly regulated by DIMM and devised a functional screen to determine the potential contributions of the candidates to DIMM action mechanisms. Figure 1 presents an overview of the work plan. As summarized in Table 1 and argued in the Discussion, these experiments suggest that the 11 targets are divisible into a ''strongly regulated'' set of six genes (direct regulation), two additional genes that may be directly targeted, and another set of three likely indirect targets. Experiment I: Embryonic RNA In Situ Hybridization We first analyzed transcript distributions for each of the 11 candidates in embryos of diverse stages and of two different genotypes (control and elav>dimm; see Supplemental Experimental Procedures for precise genotypes). Representative specimens are shown in Figure 2 ; control specimens are on the left and dimm overexpression specimens are on the right of each column. By stage 16-17 in control embryos, we observed a clear cell-specific pattern of dimm transcripts in the CNS ( [8] ; Figure 2A ). Upregulation of dimm by elav-GAL4 produced the expected panneuronal activation of dimm transcripts (Figure 2A 0 ). Transcripts for the only previously known direct DIMM target, Phm, displayed a moderate level of expression in control embryonic tissues ( Figure 2B ) and clear upregulation with DIMM overexpression ( Figure 2B 0 ), although the upregulation was not as pronounced as the one shown by dimm transcripts.
Seven other candidates (CG1275, CG13248, mael [CG11254], CG17293, CG7785, CG32850, and CG6522) displayed weak to moderate expression levels in control embryos ( Figures 2C-2H ). In the case of CG6522, transcripts were moderately to broadly expressed in normal tissues and were modestly increased with dimm overexpression (data not shown). None of these candidate targets displayed a normal expression pattern exactly matching that of dimm. CG13248 ( Figure 2D ) and CG32850 ( Figure 2H ) were broadly expressed with very prominent accumulation in paired midline cells of the ventral nerve cord. In the case of Phm and CG13248, those patterns were present early (circa stage 13) but resolved to a stronger staining pattern in lateral CNS regions later in embryogenesis that resembled that of dimm ( Figure S1 ). mael (CG11254) transcripts were not clearly detected in normal CNS ( Figure 2E ), although we clearly observed mael in normal germ cells (cf. [19] ). CG17293 was weakly expressed throughout the CNS ( Figure 2F ), and CG7785 was moderately expressed ( Figure 2G ). DIMM overexpression resulted in heightened target RNA accumulation for 7 of the 11 candidate targets. The dimmstimulated transcript patterns varied but did show some similarities: most prominently, many patterns included heavy accumulation in the paired midline cells (Figures 2B 0 -2E 0 , 2G 0 , and 2H 0 ). Such midline cells do not normally express high levels of dimm (Figure 2A) . Transcripts for the three other candidate targets (CG14621, CG31346, and pastrel [CG8588]) were not detectable in control CNS (although some were evident in nonneuronal tissues). Likewise, we could not detect them following dimm overexpression (data not shown).
In summary, 7 of the 11 candidate genes are regulated by DIMM according to embryonic-stage in situ hybridization experiments-Phm, Cyt b 561-1 , CG13248, mael, CG17293, CG7785, and CG32850. Experiment II: In Vitro Transactivation Assay Our second test for strength of regulation measured DIMM's ability to transactivate regulatory fragments of the candidate gene targets using luciferase levels as a readout. We generated test constructs containing the luciferase reporter downstream of a mini-SV promoter and the putative DIMM-binding locus of the gene. Putative DIMM-binding sites were selected by the presence and locations of specific E box sequences (CATATG or CAGCTG) based on our previous analysis [12] ; therefore, we focused especially on E boxes within the first intron. Most candidate genes contained either CATATG or CAGCTG E box sequences throughout the gene locus ( Figure S2 ). In addition, we also combined the data from chromatin immunoprecipitation (ChIP) analysis (see below). Although our earlier work on DIMM regulation of Phm utilized mammalian HEK293 cells [12] , we wished to approximate a more homologous cellular context and so tested a Drosophila neuronal cell line, BG3-c2 [20] . First, we confirmed that the positive control (Phm-sv-Luc) displayed the expected responsiveness (w10-fold induction) when dimm was cotransfected, but not when a mutant dimm isoform was cotransfected, results consistent with our previous observations [12] . Next, we measured dimm responsiveness for each of the candidate genes. We found that in addition to Phm, five candidate DIMM targets (CG1275, CG13248, mael, CG17293, and CG6522) all displayed significant transactivation responses to DIMM (Figure 3 ).
To evaluate DIMM transactivation in more detail, we constructed a series of sequence variants of the CG13248-responsive fragment-the w1 kb fragment that comprises the first intron and contains three E boxes. We mutated three of the six consensus bases of the E boxes and tested each mutated E box in single, double, and triple format; the positions of the E boxes and the results obtained are shown in Figure 3B . Once again, the wild-type CG13248 sequence produced an activity level comparable to that of Phm. Of the three single E box mutations, only E3 proved necessary for full DIMM transactivation. Furthermore, all mutant combinations containing the E3 mutation were not transactivated. Finally, the E1/E2 double mutant showed a diminished level of transactivation. In summary, the evidence points to the involvement of multiple E boxes in the transactivation of CG13248, with the E3 sequence playing the largest role. Experiment III: In Vivo Chromatin Immunoprecipitation To determine the potential occupancy by DIMM at candidate target gene binding sites in vivo, we used an epitope-tagged Fold ratios represent luciferase levels with dimm cotransfection divided by those without. Histograms represent means and standard errors of the mean (SEMs) of at least three independent replicate assays. (A) Results of testing ten DIMM targets. *p < 0.05; **p < 0.01 versus empty vector by Student's t test. (B) Results from analysis of E box sequence requirements within the CG13248 regulatory region. E1, E2, and E3 indicate three separate E boxes, which were mutated singly, doubly, or triply. *p < 0.01 versus CG13248 wildtype sequence by Student's t test. See also Figure S3 , which illustrates E box positions in and around these candidate targets.
dimm transgene and ChIP methods. The transgene-UASdimm-MYC (II)-was selectively expressed in dimm-containing neurons by using the c929-GAL4 driver. Furthermore, we restricted GAL4-UAS activities to adult stages by using temperature-sensitive GAL 80 (tub-gal80 ts ) to avoid the lethality that results from dimm overexpression at earlier stages (T.H., unpublished data). After raising the flies at the restrictive temperature (18 C), 1-to 3-day-old adults were transferred to 29 C for a 3-day period to permit expression of DIMM-MYC protein. We confirmed DIMM-MYC expression under these conditions by western blot analysis of fly head extracts and an absence of such without transfer to 29 C (data not shown).
In a previous report, we demonstrated that DIMM activates Phm directly via three palindromic E boxes (with sequences CATATG and CAGCTG) that are located in the Phm first intron [12] . Therefore, as a positive control, we asked whether DIMM is resident at this Phm intron and took a comparative approach by testing each of two sites in the Phm gene locus for DIMM occupancy-the E box-containing test site within the first intron and a control site located about 6 kb upstream (see Figure S2 ; control sites are listed in Table S2 ). Across two biological replicates, DIMM-MYC ChIPed samples for the Phm gene showed a strong (w32-fold) average enrichment over samples from the negative control genotype (c929-GAL4; tub-gal80 ts ). This difference was significantly different (p < 0.05) from the average enrichment found at its negative control site. We then asked whether DIMM is resident at the other target genes in vivo and selected test sites based on inclusion of potential DIMM-binding E boxes in the immediate 5 0 upstream or first intronic regions. Two of these candidates displayed a statistically higher level of enrichment compared to controls-CG1275 and CG6522. For seven other genes-CG13248, CG11254 (mael), CG17293, CG7785, CG32850, CG14621, and CG31436-we observed a trend for DIMM enrichment at the E box-containing site ( Figure 4 ; Table 1 ). However, these seven other examples did not achieve statistical significance.
In summary, ChIP analysis suggests that DIMM protein is normally resident in adult head DIMM cells in vivo in the regulatory DNA of at least three (Phm, CG1275, and CG6522) and likely as many as 10 of the 11 candidate targets. Furthermore, through all three independent tests of validation, 10 of 11 candidate target genes subsequently scored positive in at least one independent assay for direct DIMM regulation (summarized in Table 1 ). Five genes were responsive in all three assays (Phm, CG1275, CG13248, mael, and CG17239), and two others, CG7785 and CG6522, were responsive in two of the assays. CG32850, CG14621, and CG31436 all showed DIMM residency in vivo by ChIP, but of these three candidates, only CG32850 also displayed mRNA induction by DIMM in embryos. Only the eleventh candidate, pst, failed to show significant responsiveness in any test. Experiment IV: Adult In Vivo RNAi and LC-MS To determine whether DIMM target genes contribute to its action mechanisms, we devised a functional screen. We previously demonstrated that ectopic expression of DIMM in photoreceptor neurons confers peptidergic neuroendocrine properties onto them-photoreceptor neurons do not normally display such properties of the RSP. When such cells are also forced to express a heterologous neuropeptide precursor (ppMII), the MII peptide is fully processed [15] . We therefore used the DIMM-dependent accumulation of processed MII peptide as an endpoint assay to measure potential contributions of single candidate targets to the DIMM-generated secretory pathway. We used transgenic RNA interference (RNAi) methods to knock down individual DIMM targets exclusively within photoreceptor cells and employed quantitative mass spectrometry to analyze the processing of MII. In the control condition (GMR>dimm;ppMII), fully processed MII peptide is detected at 1710.69 m/z ratio [15] . To normalize the results of MII peptide accumulation across conditions, we also measured an endogenous Drosophila brain peptide, not found in photoreceptors, as an internal standard. For this, we chose the Drm-MT2 peptide derived from the Hugin neuropeptide precursor (SVPFKPRLamide, m/z 942.59 [21] ), because hugin-expressing neurons do not express the RNAi transgene in this experimental design. An additional negative control in this design tested the effect of an RNAi transgene for a neuropeptide precursor never found in photoreceptors-ecdysis-triggering hormone (eth) [8] .
We used both labeling and label-free quantitative mass spectrometry (MS) approaches to analyze MII and MT2 peptide levels in Drosophila head extracts using capillary liquid chromatography matrix-assisted laser desorption/ionization time-of-flight (LC-MALDI-TOF/TOF) MS. The MS-based labeling method is well validated [22, 23] but involves multiple sample-handling steps and is less effective for samples with low concentrations and small volumes. Although we were able to quantify MT2 with the labeling approach ( Figure S3 ), MII was not observed after labeling. We therefore turned to label-free quantitation because isolated peak heights can be directly compared across conditions.
Using the label-free quantitation, MT2 levels showed equal intensities in the control (GMR>dimm;ppMII) and experimental (GMR>dimm;ppMII;Phm-RNAi) samples ( Figure 5A ), consistent with labeling results ( Figure S3 ). MII levels in the experimental sample were significantly decreased from those in the control sample ( Figure 5B ). MII levels were significantly lower following knockdown of Phm, CG1275, and CG13248 ( Figure 5C ). CG17293 RNAi displayed less fully processed peptide, and CG11254 (mael) RNAi showed a trend of upregulation, but their final values did not exceed statistical significance. MII levels in the other six RNAi tests were unchanged.
In summary, 3 of 10 candidate DIMM targets (Phm, CG1275, and CG13248) make critical contributions to DIMM mechanisms. Two candidates (Phm and CG1275) are clearly involved in processing, and CG13248 may additionally be involved in overall organization of the secretory pathway (see Discussion). The functional assay that we employed was sensitive to disturbances of processing, but that is not the only interpretation for a reduction in the level of the secretory peptide. A reduced level could also result from an inability to accumulate, properly traffic, or retain secretory peptides. We did not detect a buildup of intermediates with CG13248 RNAi, and this likely indicates a defect at a stage different from processing.
The CG13248 Protein Is Enriched in DIMM Neurons and Dependent on dimm CG13248 encodes a putative cationic amino acid transporter orthologous to mammalian cationic amino acid transporter 4 (CAT-4; SLC7a4). We analyzed CG13248 protein expression using anti-CAT-4 antibodies in both the adult brain and the third-instar larval brain and evaluated it in the context of DIMM expression.
First, we performed double immunostaining with dimm neurons labeled by anti-GFP (in c929-GAL4>GFP brains). In both developmental stages, CAT-4-like immunoreactivity (IR) is heavily enriched in DIMM-positive neurons; Figure 6A shows an example of an adult brain. We also noted minorities of DIMM-only and CAT-4-only stained neurons. CAT-4-like IR was found mainly in cell bodies and terminals (data not shown) but rarely within axonal tracts. CAT-4-like IR was specific as shown by the action of a CG13248 RNAi transgenic construct: when driven by 386y-GAL4, CAT-4-like IR was lost, whereas DIMM-like IR was unaffected ( Figures 6C and 6C 0 ). 386y-GAL4 is an insertion in the prohormone convertase gene dPC2, and it drives expression in most or all dimm neurons, as well as other cells [24] .
We next asked whether CAT-4 expression is dependent on DIMM in loss-of-function and gain-of-function dimm states. We generated UAS-dimm RNAi flies, confirmed the ability of these transgenes to produce a large-scale reduction of DIMM-like IR ( Figures 6D and 6D 0 ), and observed a concomitant reduction of CAT-4-like IR ( Figures 6D and 6D 0 ). This result indicates that high-level CAT-4 expression in dimm-positive neurons depends on DIMM. To test the effects of DIMM overexpression, we turned to the four-cell Tv cluster of the larval CNS. CAT-4-like IR is normally found in two of the four Tv cluster neurons: the peptidergic Tv and Tvb but not the Tva or Tvc neurons ( Figure 6E ; cf. [25] ). We used an ap-GAL4 driver to misexpress DIMM in all four Tv cells and observed ectopic CAT-4-like expression within the Tva and Tvc cells as well (Figure 6F) . These results confirm that in vivo CAT-4 is specifically enriched in DIMM-positive cells and regulated by dimm. The distribution of CAT-4-like immunoreactivity within DIMM neurons was studied in various identified peptidergic neurons of the adult brain ( Figure S4 ), including diverse neurons of the pars intercerebralis, HUG-positive neurons of the subesophageal neuromeres, and PDF-positive large lateral neuron ventral (l-LNvs). In these neurons, CAT-4-like IR was expressed strongly by many DIMM neurons and weakly by others. It appeared principally cytoplasmic and displayed heterogeneous accumulations. 
A Computational Analysis Afforded by Prior Transcript Profiling of Mature DIMM Neurons
A recent microarray analysis of identified neurons from the adult Drosophila brain provided a fortuitous means to independently assess the authenticity of the original 134-gene list [26] . Importantly, that study was conducted on wild-type brains containing normal DIMM levels, and so it serves as a useful counterpoint to our study of DIMM overexpression. Kula-Eversole et al. [26] profiled two types of neuronsl-LNvs and small lateral neuron ventral (s-LNvs). These two identified neuron groups are similar in that both are circadian
A'' pacemakers and neuropeptide PDF-expressing cells [27] . However, they are different in that only the l-LNvs are DIMM-positive, whereas the s-LNvs are not ( [24] ; Figure 7 ; see also [13] ). Kula-Eversole et al. [26] compared l-LNvs and s-LNvs with a generic (ELAVpositive) brain neuron type for w19,000 transcripts. Using that primary data set, we identified 579 genes enriched in l-LNvs over s-LNvs. By comparing our 134-gene list derived from DIMM overexpression in embryonic stages to those 579 transcripts normally enriched in DIMM-positive cells from adult stages, we found an intersection of 18 putative DIMM direct target genes specifically enriched in adult l-LNvs versus s-LNvs ( Figure 7 ; Table S3 ). Significantly, the six DIMM targets that we identified by experimental analysis are all included in this intersection-Phm, CAT-4, mael, CG17293, CG7785, and Cyt b 561-1 .
Discussion
The experiments reported here address the mechanisms underlying DIMM's regulatory functions within peptidergic neuroendocrine cells in Drosophila. The results from a genome-wide screening revealed a diverse array of potential DIMM targets and illustrated that the scope of DIMM actions is likely broad. The actions of its direct targets appear to extend from the nucleus (CG17293) to regulation of mRNAs (CG11254) to the endoplasmic reticulum and Golgi (CG13248) to peptide-containing LDCVs (Phm and CG1254). We found no neuropeptide-encoding genes on any of our lists, even the larger 134-gene list of transcripts exhibiting upregulation with DIMM overexpression. We showed previously that DIMM is inefficient on its own at driving ectopic neuropeptide gene expression [8] [9] [10] . Together, these findings are consistent with our previous speculation that in Drosophila, specific neuropeptide expression is controlled by differing sets of transcription factors working within complex combinatorial codes [9, 13] . In contrast, DIMM provides parallel instructions for the cell biological machinery within which neuropeptides can be made, stored, and trafficked [9, 13, 15] .
Because we used an overexpression screen to generate a primary list of candidate targets, it was important to authenticate those results by reference to genes enriched in ''normal'' DIMM cells (i.e., cells in which DIMM levels were not artificially manipulated). We were fortunate to have access such information from the recently published gene array study of KulaEversole et al. [26] , from which we found that 13% of the 134 gene candidates were in fact highly enriched in DIMM-positive neurons (versus DIMM-negative peptidergic neurons). Although several candidates performed well in many of these tests and exhibit properties of direct DIMM targets, most did not score positive in all tests employed (only Phm, CG1275, CG13248, CG11254, and CG17293 did so). The results emphasize the importance of employing multiple tests to fully evaluate and properly interpret lists of regulated transcripts. Of the 11 genes passing the first test, we then used diverse experimental criteria to divide them into sets of six direct targets, two likely direct targets, and three indirect targets (Table 1) . We emphasize that our categorization of direct targets is based on highly stringent criteria and discuss here the significance of the findings for neuroendocrine cell biology.
Phm, Cyt b 561-1 , and CG13248 Are Key and Direct DIMM Mediators The inclusion of Phm and Cyt b 561-1 genes in the original list of 11 candidates increased our confidence in the list's authenticity because both play well-established roles in LDCVs [18] . Furthermore, we had demonstrated previously that Phm is a true transcriptional DIMM target both in heterologous cells and in vivo [12] . Likewise, the subsequent strong performance of Phm and Cyt b 561-1 in all four downstream assays provided further support for the validity of the experimental design to identify authentic DIMM targets.
CG13248 Is a Direct DIMM Target and Encodes a Putative Arginine Transporter, CAT-4
In addition to Phm and Cyt b 561-1 , these studies show that a third bona fide DIMM target gene, CG13248, is critical to normal regulation of neuroendocrine cell properties. Notably, in the results reported by Kula-Eversole et al. [26] , Phm, Cyt b 561-1 , and CG13248 all ranked near the top for absolute transcript abundance in DIMM-positive neurons. The identification of CG13248 as an integral component of neuroendocrine physiology is a significant new finding, but its specific contribution is a mystery because its precise molecular functions are not known. It is the clear sequence ortholog to mammalian cationic amino acid transporter 4 (CAT-4) and is therefore a candidate member of the system y+ (Na + -and pH-independent) cationic amino acid-preferring transport activities [28] .
CAT proteins form a branch of the solute carrier family 7 (SLC7) [29] . Murine CAT-1, -2, and -3 all display arginine transporter activity when heterologously expressed, but to date, CAT-4 does not [30] . Notably, the Drosophila ortholog of the CAT-1 protein is the transporter Slimfast, which mediates arginine transport in fat body and acts as a nutrient sensor [31] . In murine pancreatic acinar cells (which are regulated by the DIMM ortholog MIST1 [32] ), CAT-4 is a membrane-associated protein of secretory granules [33] . Future pursuit of the exact mechanisms by and pathways in which CAT-4 operates in DIMM-expressing neurons will help to illuminate fundamental neuroendocrine cell physiology.
Additional Direct DIMM Targets
Regarding the other direct DIMM targets, we mention a few for potential novel insights into mechanisms of neuroendocrine cell regulation. By transcript profiling, Kula-Eversole et al. [26] reported that CG11254 (maelstrom [mael] ) is highly enriched in the DIMM-positive l-LNvs. In germ cells, Mael localizes components of the microRNA pathway and contributes to cellular polarization [19] . CG17293 encodes a protein highly related to mammalian WDR82, and CG7785 encodes a protein highly related to CCLD6-both of which suggest a connection of DIMM mechanisms to chromatin-modifying properties [34] .
There were two genes that we concluded to be likely directly targeted (Table 1 , ''maybe direct''). CG6522 encodes a member of the Testin/Prickle family of proteins. Notably, the Pricklelike protein RILP interacts with REST and acts as a nuclear translocation factor [35] . The significance of potential Prickle-REST interactions is that REST displays a suppressive effect on neurosecretory properties of PC12 cells (e.g., [36] ). In addition, CG32850 encodes a protein orthologous to RING finger protein 11, which is a membrane-associated E3 ligase expressed widely in brain [37] . Finally, in the larger list of 18 genes representing the intersection of the embryonic and adult DIMM-regulated transcripts (Figure 1) , there was sizable representation of genes encoding proteins previously implicated in regulated neuropeptide secretion (Rph) and probable elements of the secretory pathway (PPADC1, RCN2, and Rabx4).
DIMM Directs a Core Program for Neuroendocrine Cells
These results define principal elements of what we anticipate will be a core program for neuroendocrine cell organization. Among mammalian basic-helix-loop-helix proteins, DIMM is most similar to MIST1 [32] . Mills and colleagues have identified several candidate MIST1 targets, including RAB3D [38] . We note that five of the six DIMM targets that responded to DIMM in the transactivation assay contained E boxes in their first exon-intron regions. The importance of first-intron E boxes has already been established for the case of Phm [12] and is also true for MIST1 target genes identified thus far [38] . Furthermore, studies of Phm and CG13248 suggest that they can define a consensus DIMM binding profile: they both contain three boxes within the first intron, two of which have the sequence CATATG, all of which contribute synergistically, and one of which appears to have the strongest contribution to DIMM transactivation. We predict that many other DIMM targets will display a similar E box profile. Furthermore, how individual target gene products contribute to the DIMM program and how many more genes are involved are now pertinent questions that will require additional studies. We anticipate that further analysis of this core DIMM program will help explain the regulatory organization of neuroendocrine cells and their evolution in different phyla. Because DIMM protein persists for the life of neuroendocrine cells in Drosophila, this work may also inform studies of neuroendocrine cell physiology and plasticity.
Developmental Generation of Peptidergic Phenotypes
In the case of neurons that utilize fast conventional neurotransmitters, transcriptional regulatory systems typically exert direct control over genes that encode biosynthetic enzymes, as well as ones for key transporter proteins that retrieve and recycle transmitters back into the lumen of synaptic vesicles [39] . For example, PET-1 supports serotonergic differentiation and directly targets genes that encode the critical biosynthetic enzyme TBH-1 and the serotonin transporter SERT1 [6] . It is striking, therefore, that our limited but highly validated list of DIMM targets similarly includes genes essential for neuropeptide biosynthesis (Phm and Cyt b 561-1 ) as well as a transporter that is specifically expressed by neuroendocrine cells (CAT-4) . We propose that there may exist an unexpected but essential parallelism in the developmental regulation of secretory systems for small transmitters and small amidated peptides. This hypothesis can help design experiments to further illuminate the mechanisms that underlie the developmental generation of peptidergic phenotypes.
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